Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × Stomach Neoplasms × trifluridine tipiracil drug combination × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 2 Stomach Neoplasms 1

Interventions

Oxaliplatin 3 Fluorouracil 3 Capecitabine 3 zolbetuximab 2 Leucovorin 2 trifluridine tipiracil drug combination 1 pembrolizumab 1 Nivolumab 1 Ipilimumab 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02500043 2024-09-03

Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric Cancer

Taiho Oncology, Inc.

Phase 3 Completed

507 enrolled 17 charts 1 FDA

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡